The start of trials is a milestone for Bayer's ambition to develop cell and gene-based therapies for Parkinson's that could replace the dopamine-producing neurons in the midbrain area that are ...

Bayer is backing up its move into the cell therapy category led by subsidiary BlueRock Therapeutics with a $250 million investment in a new manufacturing facility in Berkeley, California.

Bayer UK launches new CanesMeno Educational Hub and product range to transform menopause support: Leverkusen Friday, January 31, 2025, 17:00 Hrs [IST] Bayer Consumer Health is ent ...

FC Bayern has decided on further measures to promote its international presence and strengthen its commitment to global partnerships and fan work. Peter Romics, director of global commerce, and ...